H Li1, L Deng1, H X Bai2, J Sun2, Y Cao3, Y Tao3, L J States4, M D Farwell2, P Zhang5, B Xiao6, L Yang7. 1. From the Department of Neurology (H.L., L.D., L.Y.), Second Xiangya Hospital of Central South University, Changsha, Hunan Province, People's Republic of China. 2. Departments of Radiology (H.X.B., J.S., M.D.F.). 3. Cancer Research Institute (Y.C., Y.T.), Central South University, Changsha, Hunan Province, People's Republic of China. 4. Department of Radiology (L.J.S.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 5. Pathology (P.Z.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 6. Department of Neurology (B.X.), Xiangya Hospital of Central South University, Changsha, Hunan Province, People's Republic of China. yangli762@csu.edu.cn xiaobo_xy@126.com. 7. From the Department of Neurology (H.L., L.D., L.Y.), Second Xiangya Hospital of Central South University, Changsha, Hunan Province, People's Republic of China yangli762@csu.edu.cn xiaobo_xy@126.com.
Abstract
BACKGROUND: Current studies that analyze the usefulness of amino acid and FDG-PET in distinguishing brain metastasis recurrence and radionecrosis after radiation therapy are limited by small cohort size. PURPOSE: Our aim was to assess the diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiation therapy. DATA SOURCES: Studies were retrieved from PubMed, Embase, and the Cochrane Library. STUDY SELECTION: Fifteen studies were included from the literature. Each study used PET to differentiate radiation necrosis from tumor recurrence in contrast-enhancing lesions on follow-up brain MR imaging after treating brain metastasis with radiation therapy. DATA ANALYSIS: Data were analyzed with a bivariate random-effects model. Sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were pooled, and a summary receiver operating characteristic curve was fit to the data. DATA SYNTHESIS: The overall pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of PET were 0.85, 0.88, 7.0, 0.17, and 40, respectively. The area under the receiver operating characteristic curve was 0.93. On subgroup analysis of different tracers, amino acid and FDG-PET had similar diagnostic accuracy. Meta-regression analysis demonstrated that the method of quantification based on patient, lesion, or PET scan (based on lesion versus not, P = .07) contributed to the heterogeneity. LIMITATIONS: Our study was limited by small sample size, and 60% of the included studies were of retrospective design. CONCLUSIONS: Amino acid and FDG-PET had good diagnostic accuracy in differentiating brain metastasis recurrence from radionecrosis after radiation therapy.
BACKGROUND: Current studies that analyze the usefulness of amino acid and FDG-PET in distinguishing brain metastasis recurrence and radionecrosis after radiation therapy are limited by small cohort size. PURPOSE: Our aim was to assess the diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiation therapy. DATA SOURCES: Studies were retrieved from PubMed, Embase, and the Cochrane Library. STUDY SELECTION: Fifteen studies were included from the literature. Each study used PET to differentiate radiation necrosis from tumor recurrence in contrast-enhancing lesions on follow-up brain MR imaging after treating brain metastasis with radiation therapy. DATA ANALYSIS: Data were analyzed with a bivariate random-effects model. Sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were pooled, and a summary receiver operating characteristic curve was fit to the data. DATA SYNTHESIS: The overall pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of PET were 0.85, 0.88, 7.0, 0.17, and 40, respectively. The area under the receiver operating characteristic curve was 0.93. On subgroup analysis of different tracers, amino acid and FDG-PET had similar diagnostic accuracy. Meta-regression analysis demonstrated that the method of quantification based on patient, lesion, or PET scan (based on lesion versus not, P = .07) contributed to the heterogeneity. LIMITATIONS: Our study was limited by small sample size, and 60% of the included studies were of retrospective design. CONCLUSIONS: Amino acid and FDG-PET had good diagnostic accuracy in differentiating brain metastasis recurrence from radionecrosis after radiation therapy.
Authors: Timothy J Kaufmann; Marion Smits; Jerrold Boxerman; Raymond Huang; Daniel P Barboriak; Michael Weller; Caroline Chung; Christina Tsien; Paul D Brown; Lalitha Shankar; Evanthia Galanis; Elizabeth Gerstner; Martin J van den Bent; Terry C Burns; Ian F Parney; Gavin Dunn; Priscilla K Brastianos; Nancy U Lin; Patrick Y Wen; Benjamin M Ellingson Journal: Neuro Oncol Date: 2020-06-09 Impact factor: 12.300
Authors: Sean P Devan; Xiaoyu Jiang; Guozhen Luo; Jingping Xie; James D Quirk; John A Engelbach; Hannah Harmsen; Eliot T McKinley; Jing Cui; Zhongliang Zu; Albert Attia; Joel R Garbow; John C Gore; Colin D McKnight; Austin N Kirschner; Junzhong Xu Journal: Cancer Res Date: 2022-10-04 Impact factor: 13.312
Authors: Daniël A Korevaar; Jean-Paul Salameh; Yasaman Vali; Jérémie F Cohen; Matthew D F McInnes; René Spijker; Patrick M Bossuyt Journal: Res Synth Methods Date: 2020-02-05 Impact factor: 5.273
Authors: Robert J Young; Paula Demétrio De Souza França; Giacomo Pirovano; Anna F Piotrowski; Philip J Nicklin; Christopher C Riedl; Jazmin Schwartz; Tejus A Bale; Patrick L Donabedian; Susanne Kossatz; Eva M Burnazi; Sheryl Roberts; Serge K Lyashchenko; Alexandra M Miller; Nelson S Moss; Megan Fiasconaro; Zhigang Zhang; Audrey Mauguen; Thomas Reiner; Mark P Dunphy Journal: Neurooncol Adv Date: 2020-09-15
Authors: Ephraim E Parent; Dhruv Patel; Jonathon A Nye; Zhuo Li; Jeffrey J Olson; David M Schuster; Mark M Goodman Journal: EJNMMI Res Date: 2020-12-07 Impact factor: 3.138
Authors: Balamurugan A Vellayappan; Tresa McGranahan; Jerome Graber; Lynne Taylor; Vyshak Venur; Richard Ellenbogen; Andrew E Sloan; Kristin J Redmond; Matthew Foote; Samuel T Chao; John H Suh; Eric L Chang; Arjun Sahgal; Simon S Lo Journal: Curr Treat Options Oncol Date: 2021-06-07
Authors: Giorgio Treglia; Barbara Muoio; Gianluca Trevisi; Maria Vittoria Mattoli; Domenico Albano; Francesco Bertagna; Luca Giovanella Journal: Int J Mol Sci Date: 2019-09-20 Impact factor: 5.923